Andrea Fiorentino
Overview
Explore the profile of Andrea Fiorentino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sferrazza S, Maida M, Calabrese G, Fiorentino A, Vieceli F, Facciorusso A, et al.
Eur J Gastroenterol Hepatol
. 2024 Jul;
36(11):1281-1287.
PMID: 39012649
Objectives: Endoscopic submucosal dissection (ESD) is a minimally invasive technique for the resection of superficial gastrointestinal lesions, providing high rates of 'en bloc' and R0 resection. East-West differences in ESD...
2.
Sferrazza S, Crispino F, Vieceli F, Fiorentino A, Michielan A, De Pretis G
Endoscopy
. 2023 Apr;
55(S 01):E645-E646.
PMID: 37084786
No abstract available.
3.
Cossiga V, La Civita E, Bruzzese D, Guarino M, Fiorentino A, Sorrentino R, et al.
Front Pharmacol
. 2022 Sep;
13:891398.
PMID: 36059971
In more than 90% of chronic viral hepatitis C (HCV) patients treated with direct-acting antiviral agents (DAAs), a sustained viral response (SVR) was observed. Unfortunately, there are subgroups of subjects...
4.
Guarino M, Cossiga V, Loperto I, Esposito I, Ortolani R, Fiorentino A, et al.
Sci Rep
. 2022 Mar;
12(1):4831.
PMID: 35318432
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID-19 on LT recipients compared to general population...
5.
Rispo A, Imperatore N, Guarino M, Tortora R, Alisi A, Cossiga V, et al.
Liver Int
. 2020 Dec;
41(4):788-798.
PMID: 33319459
Background And Aims: Coeliac disease (CD) is considered a high-risk condition for developing non-alcoholic fatty liver disease (NAFLD) and other related metabolic disorders, particularly after commencing gluten-free diet (GFD). Recently,...
6.
Guarino M, Cossiga V, Fiorentino A, Pontillo G, Morisco F
J Med Internet Res
. 2020 Sep;
22(9):e20874.
PMID: 32896833
Background: The COVID-19 outbreak has overwhelmed and altered health care systems worldwide, with a substantial impact on patients with chronic diseases. The response strategy has involved implementing measures like social...
7.
Cossiga V, Lembo V, Guarino M, Tuccillo C, Morando F, Pontillo G, et al.
Nutrients
. 2020 Jan;
11(12).
PMID: 31888241
Non-alcoholic fatty liver disease (NAFLD) is associated with insulin resistance and diabetes. A reduction in insulin receptor (IR) expression has been reported in these patients. The aims of this study...
8.
Pecoraro A, Crescenzi L, Fiorentino A, Morisco F, Spadaro G
J Allergy Clin Immunol Pract
. 2019 Sep;
7(7):2507-2508.
PMID: 31495438
No abstract available.
9.
Crescenzi L, Pecoraro A, Fiorentino A, Poto R, Varricchi G, Rispo A, et al.
Dig Liver Dis
. 2019 Jun;
51(11):1599-1603.
PMID: 31155490
Background: Up to 50% of patients with common variable immunodeficiency (CVID) present persistently increased serum levels of liver enzymes and/or mild hepatomegaly. Ultrasound-based transient elastography (TE) is largely used for...